Clearstead Advisors, LLC Anavex Life Sciences Corp. Transaction History
Clearstead Advisors, LLC
- $6.3 Billion
- Q1 2025
A detailed history of Clearstead Advisors, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 481 shares of AVXL stock, worth $3,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
481
Previous 481
-0.0%
Holding current value
$3,645
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
203Shares Held
31MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$48.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$37.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$24.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$14.9 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$7.58 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $591M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...